Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas
2011

Rab25 as a Tumor Suppressor in Colon Cancer

publication Evidence: moderate

Author Information

Author(s): Goldenring J R, Nam K T

Primary Institution: Nashville VA Medical Center and Vanderbilt University School of Medicine

Hypothesis

Is Rab25 a tumor suppressor in colon carcinogenesis?

Conclusion

Loss of Rab25 is associated with poorer prognosis in colon cancer and promotes tumorigenesis in mouse models.

Supporting Evidence

  • Rab25 expression is decreased in human colon cancers independent of stage.
  • Loss of Rab25 was associated with poorer survival in colon cancer patients.
  • Rab25 deficiency in mouse models led to increased tumorigenesis.

Takeaway

Rab25 helps keep colon cells healthy, and when it's missing, it can lead to cancer.

Methodology

The study involved genetic deletion of Rab25 in mouse models and analysis of its effects on tumor development.

Limitations

The study primarily used mouse models, which may not fully replicate human cancer biology.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6605983

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication